Polymeric materials for tissue engineering of arterial substitutes

Vascular

Volumn 17, Issue SUPPL. 1, 2009, Pages

  Ravi, Swathi ^a   Qu, Zheng ^a   Chaikof, Elliot L ^a,b  

^a EMORY UNIVERSITY   (United States)

^b Georgia Institute of Technology   (United States)

Author keywords

Biodegradable scaffolds; Biopolymers; Endothelialization; Synthetic polymers; Vascular bypass grafting; Vascular tissue engineering

Indexed keywords

ARTERIAL SUBSTITUTE; BIOMATERIAL; DACRON; POLITEF; POLYMER; POLYURETHAN; UNCLASSIFIED DRUG; BIOPOLYMER; TISSUE SCAFFOLD;

BIODEGRADATION; BIOMECHANICS; BLOOD VESSEL GRAFT; CULTURE TECHNIQUE; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; VASCULAR ENDOTHELIUM; VASCULAR PATENCY; ANIMAL; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; ENDOTHELIUM CELL; HUMAN; METHODOLOGY; PERIPHERAL VASCULAR DISEASE;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOPOLYMERS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; ENDOTHELIAL CELLS; HUMANS; PERIPHERAL VASCULAR DISEASES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 70349245420     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2008.00084     Document Type: Review

References (158)

1. American Heart Association: Heart disease and stroke statistics - 2008 update. Available at: http://www.americanheart.org/ presenter.jhtml?identifier51928 (accessed August 2, 2008).
2. Berger PB, Alderman EL, Nadel A, et al. Frequency of early occlusion and stenosis in a left internal mammary artery to left anterior descending artery bypass graft after surgery through a median sternotomy on conventional bypass: benchmark for minimally invasive direct coronary artery bypass. Circulation 1999;100:2353-8.
3. Verma S, Szmitko PE, Weisel RD, et al. Should radial arteries be used routinely for coronary artery bypass grafting? Circulation 2004;110:e40-6.
4. McKee JA, Banik SS, Boyer MJ, et al. Human arteries engineered in vitro. EMBO Rep 2003;4:633-8.
5. Ratner BD. Biomaterials science: an introduction to materials in medicine. 2nd ed. Amsterdam: Elsevier Academic Press; 2004.
6. Blakemore AH, Voorhees AB Jr. The use of tubes constructed from Vinyon N cloth in bridging arterial defects; experimental and clinical. Ann Surg 1954;140:324-34.
7. Kannan RY, Salacinski HJ, Butler PE, et al. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater 2005;74:570-81.
8. Abbott WM, Megerman J, Hasson JE, et al. Effect of compliance mismatch on vascular graft patency. J Vasc Surg 1987;5:376-82.
9. Wittemore AD, Kent KC, Donaldson MC, et al. What is the proper role of polytetrafluoroethylene grafts in infrainguinal reconstruction? J Vasc Surg 1989;10:299-305.
10. Greisler HP. Interactions at the blood/material interface. Ann Vasc Surg 1990;4:98-103.
11. Conte MS. The ideal small arterial substitute: a search for the Holy Grail? FASEB J 1998;12:43-5.
12. Humphrey JD. Mechanics of the arterial wall: review and directions. Crit Rev Biomed Eng 1995;23:1-162.
13. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986;231:397-400.
14. Johnson WC, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 2000;32:268-77.
15. Xue L, Greisler HP. Biomaterials in the development and future of vascular grafts. J Vasc Surg 2003;37:472-80.
16. Clowes AW, Kirkman TR, Reidy MA. Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. Am J Pathol 1986;123:220-30.
17. Goldman M, McCollum CN, Hawker RJ, et al. Dacron arterial grafts: the influence of porosity, velour, and maturity on thrombogenicity. Surgery 1982;92:947-52.
18. Hamlin GW, Rajah SM, Crow MJ, et al. Evaluation of the thrombogenic potential of three types of arterial graft studied in an artificial circulation. Br J Surg 1978;65:272-6.
19. 111indium-platelet deposition predict patency in prosthetic arterial grafts? Br J Surg 1983; 70:635-8.
20. Allen BT, Mathias CJ, Sicard GA, et al. Platelet deposition on vascular grafts. The accuracy of in vivo quantitation and the significance of in vivo platelet reactivity. Ann Surg 1986;203:318-28.
21. Shepard AD, Gelfand JA, Callow AD, et al. Complement activation by synthetic vascular prostheses. J Vasc Surg 1984;1: 829-38.
22. Abbott WM, Green RM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. J Vasc Surg 1997;25:19-28.
23. Kapfer X, Meichelboeck W, Groegler FM. Comparison of carbon-impregnated and standard ePTFE prostheses in extra-anatomical anterior tibial artery bypass: a prospective randomized multicenter study. Eur J Vasc Endovasc Surg 2006;32:155-68.
24. Nishibe T, O'Donnel S, Pikoulis E, et al. Effects of fibronectin bonding on healing of high porosity expanded polytetrafluoroethylene grafts in pigs. J Cardiovasc Surg (Torino) 2001;42:667-73.
25. Li C, Hill A, Imran M. In vitro and in vivo studies of ePTFE vascular grafts treated with P15 peptide. J Biomater Sci Polym Ed 2005;16:875-91.
26. Krijgsman B, Seifalian AM, Salacinski HJ, et al. An assessment of covalent grafting of RGD peptides to the surface of a compliant poly(carbonate-urea)urethane vascular conduit versus conventional biological coatings: its role in enhancing cellular retention. Tissue Eng 2002;8:673-80.
27. Walluscheck KP, Steinhoff G, Kelm S, et al. Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides. Eur J Vasc Endovasc Surg 1996;12: 321-30.
28. Meinhart JG, Schense JC, Schima H, et al. Enhanced endothelial cell retention on shear-stressed synthetic vascular grafts precoated with RGD-cross-linked fibrin. Tissue Eng 2005;11:887-95.
29. Greisler HP, Cziperle DJ, Kim DU, et al. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery 1992;112:244-54; discussion 254-5.
30. Greisler HP, Gosselin C, Ren D, et al. Biointeractive polymers and tissue engineered blood vessels. Biomaterials 1996;17:329-36.
31. Gray JL, Kang SS, Zenni GC, et al. FGF-1 affixation stimulates ePTFE endothelialization without intimal hyperplasia. J Surg Res 1994;57:596-612.
32. Greisler HP, Klosak JJ, Dennis JW, et al. Biomaterial pretreatment with ECGF to augment endothelial cell proliferation. J Vasc Surg 1987;5:393-9.
33. Randone B, Cavallaro G, Polistena A, et al. Dual role of VEGF in pretreated experimental ePTFE arterial grafts. J Surg Res 2005;127: 70-9.
34. Greisler HP, Schwarcz TH, Ellinger J, et al. Dacron inhibition of arterial regenerative activities. J Vasc Surg 1986;3:747-56.
35. Yu TJ, Chu CC. Bicomponent vascular grafts consisting of synthetic absorbable fibers. I. In vitro study. J Biomed Mater Res 1993;27:1329-39.
36. Yu TJ, Ho DM, Chu CC. Bicomponent vascular grafts consisting of synthetic absorbable fibers: part II: in vivo healing response. J Invest Surg 1994;7:195-211.
37. Seifalian AM, Salacinski HJ, Tiwari A, et al. In vivo biostability of a poly(carbonate-urea)urethane graft. Biomaterials 2003;24:2549-57.
38. Nakagawa Y, Ota K, Teraoka S, et al. Experimental studies on improved polyester-polyurethane vascular grafts for hemodialysis. ASAIO Trans 1991;37:M273-4.
39. Nakagawa Y, Ota K, Sato Y, et al. Clinical trial of new polyurethane vascular grafts for hemodialysis: compared with expanded polytetrafluoroethylene grafts. Artif Organs 1995;19: 1227-32.
40. Ota K, Nakagawa Y, Kitano Y, et al. Clinical application of modified polyurethane graft to blood access. Artif Organs 1991; 15:449-53.
41. Doi K, Matsuda T. Enhanced vascularization in a microporous polyurethane graft impregnated with basic fibroblast growth factor and heparin. J Biomed Mater Res 1997;34:361-70.
42. Izhar U, Schwalb H, Borman JB, et al. Novel synthetic selectively degradable vascular prostheses: a preliminary implantation study. J Surg Res 2001;95:152-60.
43. Herring M, Gardner A, Glover J. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery 1978;84:498-504.
44. Zilla P, Fasol R, Deutsch M, et al. Endothelial cell seeding of polytetrafluoroethylene vascular grafts in humans: a preliminary report. J Vasc Surg 1987;6:535-41.
45. Herring M, Smith J, Dalsing M, et al. Endothelial seeding of polytetrafluoroethylene femoral popliteal bypasses: the failure of low-density seeding to improve patency. J Vasc Surg 1994;20:650-5.
46. Jensen N, Lindblad B, Bergqvist D. Endothelial cell seeded Dacron aortobifurcated grafts: platelet deposition and long-term follow-up. J Cardiovasc Surg (Torino) 1994;35:425-9.
47. Graham LM, Vinter DW, Ford JW, et al. Cultured autogenous endothelial cell seeding of prosthetic vascular grafts. Surg Forum 1979;30:204-6.
48. Lindblad B, Wright SW, Sell RL, et al. Alternative techniques of seeding cultured endothelial cells to ePTFE grafts of different diameters, porosities, and surfaces. J Biomed Mater Res 1987;21: 1013-22.
49. Zilla P, Deutsch M, Meinhart J, et al. Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J Vasc Surg 1994;19:540-8.
50. Deutsch M, Meinhart J, Fischlein T, et al. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery 1999;126:847-55.
51. Meinhart JG, Deutsch M, Fischlein T, et al. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg 2001;71(5 Suppl):S327-31.
52. Laube HR, Duwe J, Rutsch W, et al. Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. J Thorac Cardiovasc Surg 2000;120: 134-41.
53. Salacinski HJ, Tiwari A, Hamilton G, et al. Cellular engineering of vascular bypass grafts: role of chemical coatings for enhancing endothelial cell attachment. Med Biol Eng Comput 2001;39:609-18.
54. Bowlin GL, Meyer A, Fields C, et al. The persistence of electrostatically seeded endothelial cells lining a small diameter expanded polytetrafluoroethylene vascular graft. J Biomater Appl 2001;16:157-73.
55. Fields C, Cassano A, Makhoul RG, et al. Evaluation of electrostatically endothelial cell seeded expanded polytetrafluoroethylene grafts in a canine femoral artery model. J Biomater Appl 2002;17:135-52.
56. Ballermann BJ, Ott MJ. Adhesion and differentiation of endothelial cells by exposure to chronic shear stress: a vascular graft model. Blood Purif 1995;13:125-34.
57. Isenberg BC, Williams C, Tranquillo RT. Endothelialization and flow conditioning of fibrin-based media-equivalents. Ann Biomed Eng 2006;34:971-85.
58. Fujita Y, Wu MH, Ishida A, et al. Accelerated healing of Dacron grafts seeded by preclotting with autologous bone marrow blood. Ann Vasc Surg 1999;13:402-12.
59. Bhattacharya V, McSweeney PA, Shi Q, et al. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 2000;95:581-5.
60. Griese DP, Ehsan A, Melo LG, et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003;108:2710-5.
61. Jarrell BE, Williams SK, Stokes G, et al. Use of freshly isolated capillary endothelial cells for the immediate establishment of a monolayer on a vascular graft at surgery. Surgery 1986;100:392-9.
62. Pasic M, Muller-Glauser W, Odermatt B, et al. Seeding with omental cells prevents late neointimal hyperplasia in small-diameter Dacron grafts. Circulation 1995;92:2605-16.
63. Pasic M, Muller-Glauser W, von Segesser LK, et al. Superior late patency of small-diameter Dacron grafts seeded with omental microvascular cells: an experimental study. Ann Thorac Surg 1994;58:677-83; discussion 683-4.
64. Tiwari A, Kidane A, Punshon G, et al. Extraction of cells for single-stage seeding of vascular-bypass grafts. Biotechnol Appl Biochem 2003;38(Pt 1):35-41.
65. Clagett GP, Burkel WE, Sharefkin JB, et al. Platelet reactivity in vivo in dogs with arterial prostheses seeded with endothelial cells. Circulation 1984;69:632-9.
66. Gosselin C, Vorp DA, Warty V, et al. ePTFE coating with fibrin glue, FGF-1, and heparin: effect on retention of seeded endothelial cells. J Surg Res 1996;60:327-32.
67. Herring MB, Dilley R, Jersild RA Jr, et al. Seeding arterial prostheses with vascular endothelium. The nature of the lining. Ann Surg 1979;190:84-90.
68. Hubbell JA, Massia SP, Desai NP, et al. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology (N Y) 1991;9:568-72.
69. Seifalian AM, Tiwari A, Hamilton G, et al. Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs 2002;26:307-20.
70. Zilla P, Deutsch M, Meinhart J. Endothelial cell transplantation. Semin Vasc Surg 1999;12:52-63.
71. Hedeman Joosten PP, Verhagen HJ, Heijnen-Snyder GJ, et al. Thrombogenesis of different cell types seeded on vascular grafts and studied under blood-flow conditions. J Vasc Surg 1998;28: 1094-103.
72. Pearson JD. Endothelial cell function and thrombosis. Baillieres Best Pract Res Clin Haematol 1999;12:329-41.
73. Greisler HP, Wise D, Trantolo D, et al. Regulation of vascular graft healing by induction of tissue incorporation. In: Donald L. Wise, editor. Human biomaterials applications. Totowa (NJ): Humana Press; 1996. p. 227.
74. Rotmans JI, Heyligers JM, Verhagen HJ, et al. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 2005;112: 12-8.
75. Kim BS, Mooney DJ. Engineering smooth muscle tissue with a predefined structure. J Biomed Mater Res 1998;41:322-32.
76. Mooney DJ, Mazzoni CL, Breuer C, et al. Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials 1996; 17:115-24.
77. Wake MC, Gupta PK, Mikos AG. Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplant 1996;5:465-73.
78. Mooney DJ, Organ G, Vacanti JP, et al. Design and fabrication of biodegradable polymer devices to engineer tubular tissues. Cell Transplant 1994;3:203-10.
79. Fidkowski C, Kaazempur-Mofrad MR, Borenstein J, et al. Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng 2005;11:302-9.
80. Niklason LE, Gao J, Abbott WM, et al. Functional arteries grown in vitro. Science 1999;284:489-93.
81. Shum-Tim D, Stock U, Hrkach J, et al. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 1999;68:2298-304; discussion 2305.
82. Fu P, Sodian R, Luders C, et al. Effects of basic fibroblast growth factor and transforming growth factor-beta on maturation of human pediatric aortic cell culture for tissue engineering of cardiovascular structures. ASAIO J 2004;50:9-14.
83. Shin'oka T, Shum-Tim D, Ma PX, et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998;115:536-45; discussion 545-6.
84. Watanabe M, Shin'oka T, Tohyama S, et al. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng 2001;7:429-39.
85. Shin'oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001;344:532-3.
86. Shin'oka T, Matsumura G, Hibino N, et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005; 129:1330-8.
87. Matsumura G, Ishihara Y, Miyagawa-Tomita S, et al. Evaluation of tissue-engineered vascular autografts. Tissue Eng 2006;12: 3075-83.
88. Ennett AB, Kaigler D, Mooney DJ. Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater Res A 2006;79: 176-84.
89. Guan J, Stankus JJ, Wagner WR. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J Control Release 2007;120:70-8.
90. Alberts B, Bray D, Lewis J, et al. Molecular biology of the cell. 3rd ed. New York: Garland Publishing; 1994.
91. Buttafoco L, Kolkman NG, Engbers-Buijtenhuijs P, et al. Electrospinning of collagen and elastin for tissue engineering applications. Biomaterials 2006;27:724-34.
92. Ottani V, Raspanti M, Ruggeri A. Collagen structure and functional implications. Micron 2001;32:251-60.
93. Nicolas FL, Gagnieu CH. Denatured thiolated collagen. II. Crosslinking by oxidation. Biomaterials 1997;18:815-21.
94. Habermehl J, Skopinska J, Boccafoschi F, et al. Preparation of ready-to-use, stockable and reconstituted collagen. Macromol Biosci 2005;5:821-8.
95. Charulatha V, Rajaram A. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials 2003;24:759-67.
96. Elbjeirami WM, Yonter EO, Starcher BC, et al. Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity. J Biomed Mater Res A 2003;66: 513-21.
97. Brinkman WT, Nagapudi K, Thomas BS, et al. Photo-crosslinking of type I collagen gels in the presence of smooth muscle cells: mechanical properties, cell viability, and function. Biomacromolecules 2003;4:890-5.
98. Orban JM, Wilson LB, Kofroth JA, et al. Crosslinking of collagen gels by transglutaminase. J Biomed Mater Res A 2004;68:756-62.
99. Hirai J, Matsuda T. Self-organized, tubular hybrid vascular tissue composed of vascular cells and collagen for low-pressure-loaded venous system. Cell Transplant 1995;4:597-608.
100. Nerem RM, Ensley AE. The tissue engineering of blood vessels and the heart. Am J Transplant 2004;4Suppl 6:36-42.
101. Nerem RM, Seliktar D. Vascular tissue engineering. Annu Rev Biomed Eng 2001;3:225-43.
102. Baguneid M, Murray D, Salacinski HJ, et al. Shear-stress preconditioning and tissue-engineering-based paradigms for generating arterial substitutes. Biotechnol Appl Biochem 2004; 39(Pt 2):151-7.
103. L'Heureux N, Germain L, Labbe R, et al. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J Vasc Surg 1993;17:499-509.
104. Seliktar D, Black RA, Vito RP, et al. Dynamic mechanical conditioning of collagen-gel blood vessel constructs induces remodeling in vitro. Ann Biomed Eng 2000;28:351-62.
105. Cummings CL, Gawlitta D, Nerem RM, et al. Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 2004;25:3699-706.
106. Ye Q, Zund G, Benedikt P, et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2000;17:587-91.
107. Clark RA. Fibrin glue for wound repair: facts and fancy. Thromb Haemost 2003;90:1003-6.
108. Jockenhoevel S, Zund G, Hoerstrup SP, et al. Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2001;19:424-30.
109. Long JL, Tranquillo RT. Elastic fiber production in cardiovascular tissue-equivalents. Matrix Biol 2003;22:339-50.
110. Grassl ED, Oegema TR, Tranquillo RT. A fibrin-based arterial media equivalent. J Biomed Mater Res A 2003;66:550-61.
111. Swartz DD, Russell JA, Andreadis ST. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol 2005;288:H1451-60.
112. Patel A, Fine B, Sandig M, et al. Elastin biosynthesis: the missing link in tissue-engineered blood vessels. Cardiovasc Res 2006;71: 40-9.
113. Silver FH, Horvath I, Foran DJ. Viscoelasticity of the vessel wall: the role of collagen and elastic fibers. Crit Rev Biomed Eng 2001; 29:279-301.
114. Silver FH, Snowhill PB, Foran DJ. Mechanical behavior of vessel wall: a comparative study of aorta, vena cava, and carotid artery. Ann Biomed Eng 2003;31:793-803.
115. Lillie MA, Gosline JM. The viscoelastic basis for the tensile strength of elastin. Int J Biol Macromol 2002;30:119-27.
116. Ramamurthi A, Vesely I. Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves. Biomaterials 2005;26:999-1010.
117. Stock UA, Wiederschain D, Kilroy SM, et al. Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures. J Cell Biochem 2001;81:220-8.
118. Isenberg BC, Tranquillo RT. Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann Biomed Eng 2003;31:937-49.
119. Daamen WF, Hafmans T, Veerkamp JH, et al. Comparison of five procedures for the purification of insoluble elastin. Biomaterials 2001;22:1997-2005.
120. Buijtenhuijs P, Buttafoco L, Poot AA, et al. Tissue engineering of blood vessels: characterization of smooth-muscle cells for culturing on collagen-and-elastin-based scaffolds. Biotechnol Appl Biochem 2004;39(Pt 2):141-9.
121. Nagapudi K, Brinkman WT, Thomas BS, et al. Viscoelastic and mechanical behavior of recombinant protein elastomers. Biomaterials 2005;26:4695-706.
122. Meyer DE, Chilkoti A. Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system. Biomacromolecules 2002;3: 357-67.
123. Cappello J, Crissman J, Dorman M, et al. Genetic engineering of structural protein polymers. Biotechnol Prog 1990;6:198-202.
124. McGrath KP, Tirrell DA, Kawai M, et al. Chemical and biosynthetic approaches to the production of novel polypeptide materials. Biotechnol Prog 1990;6:188-92.
125. Petka WA, Harden JL, McGrath KP, et al. Reversible hydrogels from self-assembling artificial proteins. Science 1998;281:389-92.
126. Urry DW. Physical chemistry of biological free energy transduction as demonstrated by elastin protein-based polymers. J Phys Chem B 1997;101:11007-28.
127. Urry DW. Five axioms for the functional design of peptide-based polymers as molecular machines and materials: principles for macromolecular assembly. Biopolymers 1998;47:167-78.
128. Chang DK, Urry DK. Molecular dynamics calculations on relaxed and extended states of the polypentapeptide of elastin. Chem Phys Lett 1988;147:395-400.
129. van Hest JC, Tirrell DA. Protein-based materials, toward a new level of structural control. Chem Commun (Camb) 2001;19: 1897-904.
130. Wright ER, McMillan RA, Cooper A, et al. Thermoplastic elastomer hydrogels via self-assembly of an elastin-mimetic triblock polypeptide. Adv Funct Mater 2002;12:1-6.
131. Wright ER, Conticello VP. Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences. Adv Drug Deliv Rev 2002;54:1057-73.
132. Kwon IK, Kidoaki S, Matsuda T. Electrospun nano- to microfiber fabrics made of biodegradable copolyesters: structural characteristics, mechanical properties and cell adhesion potential. Biomaterials 2005;26:3929-39.
133. Li M, Mondrinos MJ, Gandhi MR, et al. Electrospun protein fibers as matrices for tissue engineering. Biomaterials 2005;26: 5999-6008.
134. Dahl SL, Koh J, Prabhakar V, et al. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant 2003;12:659-66.
135. Schmidt CE, Baier JM. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000;21:2215-31.
136. Tamura N, Nakamura T, Terai H, et al. A new acellular vascular prosthesis as a scaffold for host tissue regeneration. Int J Artif Organs 2003;26:783-92.
137. Uchimura E, Sawa Y, Taketani S, et al. Novel method of preparing acellular cardiovascular grafts by decellularization with poly (ethylene glycol). J Biomed Mater Res A 2003;67:834-7.
138. Courtman DW, Errett BF, Wilson GJ. The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. J Biomed Mater Res 2001;55:576-86.
139. Khor E. Methods for the treatment of collagenous tissues for bioprostheses. Biomaterials 1997;18:95-105.
140. Amiel GE, Komura M, Shapira O, et al. Engineering of blood vessels from acellular collagen matrices coated with human endothelial cells. Tissue Eng 2006;12:2355-65.
141. Cho SW, Lim SH, Kim IK, et al. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 2005;241: 506-15.
142. Conklin BS, Richter ER, Kreutziger KL, et al. Development and evaluation of a novel decellularized vascular xenograft. Med Eng Phys 2002;24:173-83.
143. Conklin BS, Wu H, Lin PH, et al. Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft. Artif Organs 2004;28:668-75.
144. DiMuzio P, Fischer L, McIlhenny S, et al. Development of a tissue-engineered bypass graft seeded with stem cells. Vascular 2006;14:338-42.
145. Holdsworth RJ, Naidu S, Gervaz P, et al. Glutaraldehyde-tanned bovine carotid artery graft for infrainguinal vascular reconstruction: 5-year follow-up. Eur J Vasc Endovasc Surg 1997;14: 208-11.
146. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001;7:1035-40.
147. McFetridge PS, Bodamyali T, Horrocks M, et al. Endothelial and smooth muscle cell seeding onto processed ex vivo arterial scaffolds using 3D vascular bioreactors. ASAIO J 2004;50:591-600.
148. Shimizu K, Ito A, Arinobe M, et al. Effective cell-seeding technique using magnetite nanoparticles and magnetic force onto decellularized blood vessels for vascular tissue engineering. J Biosci Bioeng 2007;103:472-8.
149. Voytik-Harbin SL, Brightman AO, Kraine MR, et al. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem 1997;67:478-91.
150. Badylak SF, Record R, Lindberg K, et al. Small intestinal submucosa: a substrate for in vitro cell growth. J Biomater Sci Polym Ed 1998;9:863-78.
151. Robotin-Johnson MC, Swanson PE, Johnson DC, et al. An experimental model of small intestinal submucosa as a growing vascular graft. J Thorac Cardiovasc Surg 1998;116:805-11.
152. Huynh T, Abraham G, Murray J, et al. Remodeling of an acellular collagen graft into a physiologically responsive neovessel. Nat Biotechnol 1999;17:1083-6.
153. Marshall SE, Tweedt SM, Greene CH, et al. An alternative to synthetic aortic grafts using jejunum. J Invest Surg 2000;13: 333-41.
154. Campbell GR, Ryan GB. Origin of myofibroblasts in the avascular capsule around free-floating intraperitoneal blood clots. Pathology 1983;15:253-64.
155. Campbell JH, Efendy JL, Han C, et al. Haemopoietic origin of myofibroblasts formed in the peritoneal cavity in response to a foreign body. J Vasc Res 2000;37:364-71.
156. Campbell JH, Efendy JL, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res 1999;85: 1173-8.
157. Chue WL, Campbell GR, Caplice N, et al. Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts. J Vasc Surg 2004;39:859-67.
158. Efendy JL, Campbell GR, Campbell JH. The effect of environmental cues on the differentiation of myofibroblasts in peritoneal granulation tissue. J Pathol 2000;192:257-62.